Wave life sciences fourth quarter and full year 2024 financial results scheduled for march 4, 2025

Cambridge, mass., feb. 25, 2025 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage biotechnology company focused on unlocking the broad potential of rna medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. et on tuesday, march 4, 2025, to review the company's fourth quarter and full year 2024 financial results and provide business updates.
WVE Ratings Summary
WVE Quant Ranking